CALQUENCE

ACALABRUTINIB · AstraZeneca Pharmaceuticals LP

Drug timelines are a Plus or Pro feature.

73 regulatory and trial events tracked for CALQUENCE, covering 2016-05-13 to 2026-07-06. Get the full timeline:

Most recent: EMA Authorised: Calquence (acalabrutinib;acalabrutinib maleate) — AstraZeneca AB